110 related articles for article (PubMed ID: 9809982)
21. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
Schiemann WP; Rotzer D; Pfeifer WM; Levi E; Rai KR; Knaus P; Kadin ME
Cancer Detect Prev; 2004; 28(1):57-64. PubMed ID: 15041079
[TBL] [Abstract][Full Text] [Related]
22. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.
Yamada SD; Baldwin RL; Karlan BY
Gynecol Oncol; 1999 Oct; 75(1):72-7. PubMed ID: 10502429
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1.
Wilder PJ; Bernadt CT; Kim JH; Rizzino A
Mol Reprod Dev; 2002 Nov; 63(3):282-90. PubMed ID: 12237943
[TBL] [Abstract][Full Text] [Related]
24. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
[TBL] [Abstract][Full Text] [Related]
25. Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.
Garrigue-Antar L; Souza RF; Vellucci VF; Meltzer SJ; Reiss M
Lab Invest; 1996 Aug; 75(2):263-72. PubMed ID: 8765326
[TBL] [Abstract][Full Text] [Related]
26. TbetaR-I(6A) is a candidate tumor susceptibility allele.
Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
Gemma A; Uematsu K; Hagiwara K; Takenoshita S; Kudoh S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
[TBL] [Abstract][Full Text] [Related]
28. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
32. Localization of recognition site between transforming growth factor-beta1 (TGF-beta1) and TGF beta receptor type II: possible implications in breast cancer.
Ivanović V; Demajo M; Todorović-Raković N; Nikolić-Vukosavljević D; Nesković-Konstantinović Z; Krtolica K; Veljković V; Prljić J; Dimitrijević B
Med Hypotheses; 2004; 62(5):727-32. PubMed ID: 15082097
[TBL] [Abstract][Full Text] [Related]
33. Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma.
Muro-Cacho CA; Anderson M; Cordero J; Muñoz-Antonia T
Clin Cancer Res; 1999 Jun; 5(6):1243-8. PubMed ID: 10389906
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of eEF1A1 at Ser300 by TβR-I results in inhibition of mRNA translation.
Lin KW; Yakymovych I; Jia M; Yakymovych M; Souchelnytskyi S
Curr Biol; 2010 Sep; 20(18):1615-25. PubMed ID: 20832312
[TBL] [Abstract][Full Text] [Related]
35. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
36. TGF-beta control of cell proliferation.
Huang SS; Huang JS
J Cell Biochem; 2005 Oct; 96(3):447-62. PubMed ID: 16088940
[TBL] [Abstract][Full Text] [Related]
37. Redirection of B cell responsiveness by transforming growth factor beta receptor.
Roes J; Choi BK; Cazac BB
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7241-6. PubMed ID: 12773615
[TBL] [Abstract][Full Text] [Related]
38. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract.
Pasche B; Luo Y; Rao PH; Nimer SD; Dmitrovsky E; Caron P; Luzzatto L; Offit K; Cordon-Cardo C; Renault B; Satagopan JM; Murty VV; Massagué J
Cancer Res; 1998 Jul; 58(13):2727-32. PubMed ID: 9661882
[TBL] [Abstract][Full Text] [Related]
39. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
[TBL] [Abstract][Full Text] [Related]
40. Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes.
Bernadt CT; Rizzino A
Mol Reprod Dev; 2003 Aug; 65(4):353-65. PubMed ID: 12840808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]